# Camp4 Therapeutics Corp: Form 8-K, filed Oct 15, 2024

- Company: [Camp4 Therapeutics Corp](/companies/camp.md) (CIK 1736730)
- Form: 8-K
- Filed: 2024-10-15
- Accepted by EDGAR: Oct 15, 2024, 16:06 ET
- Period: 2024-10-15
- Accession: 0001104659-24-108583
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736730/000110465924108583/tm2426167d1_8k.htm

Filed Oct 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-108583. Last ingested by Listed: Nov 5, 2026, 17:42 ET. No prices; not investment advice.